AVITA Medical (RCEL) Return on Capital Employed (2020 - 2025)
AVITA Medical (RCEL) posted Return on Capital Employed of 1625.37% for Q4 2025, down 65.24% on a QoQ basis from 4676.11% in Q3 2025, and up 171934.0% year-over-year from N/an in Q4 2024.
AVITA Medical (RCEL) Return on Capital Employed (2020 - 2025) Analysis & Trends
AVITA Medical's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 1625.37% for Q4 2025.
- Quarterly Return on Capital Employed rose 171934.0% year-over-year to 1625.37% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1625.37% (up 171934.0% YoY) and the FY2025 annual result came in at 791.4%, down 71646.0% from the prior year.
- Return on Capital Employed was 1625.37% for Q4 2025 at AVITA Medical, down from 4676.11% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 4676.11% in Q3 2025 and bottomed at 3760.1% in Q2 2025.
- A 5-year average of 96.36% and a median of 44.73% in 2022 frame the typical range for Return on Capital Employed.
- Peak annual rise in Return on Capital Employed reached 476365 bps in 2025, while the deepest fall reached 370120 bps in 2025.
- AVITA Medical's Return on Capital Employed stood at 33.51% in 2021, then slumped by 41 bps to 47.26% in 2022, then decreased by 9 bps to 51.31% in 2023, then tumbled by 83 bps to 93.97% in 2024, then soared by 1830 bps to 1625.37% in 2025.
- Business Quant data shows RCEL's Return on Capital Employed at 1625.37% in Q4 2025, 4676.11% in Q3 2025, and 3760.1% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 1,625.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,625.37% |
| Sep 30, 2025 | 4,676.11% |
| Jun 30, 2025 | -3,760.10% |
| Mar 31, 2025 | -99.10% |
| Dec 31, 2024 | -93.97% |
| Sep 30, 2024 | -87.54% |
| Jun 30, 2024 | -58.90% |
| Mar 31, 2024 | -47.89% |
| Dec 31, 2023 | -51.31% |
| Sep 30, 2023 | -56.07% |
| Jun 30, 2023 | -41.15% |
| Mar 31, 2023 | -41.74% |
| Dec 31, 2022 | -47.26% |
| Sep 30, 2022 | -42.21% |
| Mar 31, 2022 | -40.87% |
| Sep 30, 2021 | -33.51% |
| Jun 30, 2021 | -27.24% |
| Mar 31, 2021 | -38.04% |
| Dec 31, 2020 | -68.65% |
| Sep 30, 2020 | -69.13% |